{"title":"治疗疟疾的儿童因伯氨喹引起的高铁血红蛋白血症","authors":"Sara Puerta, Hardenson Rodríguez","doi":"10.7705/biomedica.7194","DOIUrl":null,"url":null,"abstract":"<p><p>Methemoglobinemia results from an increased concentration of methemoglobin in the blood, impairing oxygen delivery to tissues. It is considered a rare condition that requires a high diagnostic suspicion.\nWe report the case of a pediatric patient with malaria who presented with cyanosis and hypoxemia as manifestations of methemoglobinemia induced by primaquine treatment.\nThe patient responded adequately after antimalarial drug suspension and ascorbic acid administration.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"45 1","pages":"9-16"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097778/pdf/","citationCount":"0","resultStr":"{\"title\":\"Primaquine-induced methemoglobinemia in a child treated for malaria\",\"authors\":\"Sara Puerta, Hardenson Rodríguez\",\"doi\":\"10.7705/biomedica.7194\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Methemoglobinemia results from an increased concentration of methemoglobin in the blood, impairing oxygen delivery to tissues. It is considered a rare condition that requires a high diagnostic suspicion.\\nWe report the case of a pediatric patient with malaria who presented with cyanosis and hypoxemia as manifestations of methemoglobinemia induced by primaquine treatment.\\nThe patient responded adequately after antimalarial drug suspension and ascorbic acid administration.</p>\",\"PeriodicalId\":101322,\"journal\":{\"name\":\"Biomedica : revista del Instituto Nacional de Salud\",\"volume\":\"45 1\",\"pages\":\"9-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097778/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedica : revista del Instituto Nacional de Salud\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7705/biomedica.7194\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedica : revista del Instituto Nacional de Salud","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7705/biomedica.7194","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Primaquine-induced methemoglobinemia in a child treated for malaria
Methemoglobinemia results from an increased concentration of methemoglobin in the blood, impairing oxygen delivery to tissues. It is considered a rare condition that requires a high diagnostic suspicion.
We report the case of a pediatric patient with malaria who presented with cyanosis and hypoxemia as manifestations of methemoglobinemia induced by primaquine treatment.
The patient responded adequately after antimalarial drug suspension and ascorbic acid administration.